Abd Razak, Dzulkifli
(2006)
Curing the highcost-syndrome.
New Sunday Times.
Abstract
The Health Ministry's announcement last week that it is working on a proposal to cap the prices of more than
1,000 essential medicines is welcome, though the move is long overdue.
For a long time, the question of drugs has been a bone of contention between Malaysian health activists and
consumers. The last time Malaysia discussed this issue was almost a decade ago but it was of little avail.
Maybe this time it will be different.
A survey recently (NST, May 9) showed that many Malaysians pay exorbitant prices for their medicines. In
fact, drug prices in Malaysia are far above the international reference pricing, a guide on how much medicine
should cost.
The ministry's list of essential medicines will include antibiotics, aspirin and other painkillers, as well as
medicines for high blood pressure and depression.
Actions (login required)
 |
View Item |
![[img]](http://eprints.usm.my/style/images/fileicons/application_pdf.png)
